Negative Antibody Response to Long-Term Treatment of Facial Spasm With Botulinum Toxin
- 1 March 1988
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 105 (3) , 313-315
- https://doi.org/10.1016/0002-9394(88)90016-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Effectiveness of Botulinum Toxin Therapy for Essential BlepharospasmOphthalmology, 1987
- Use of BotuIinum Toxin in the Treatment of One Hundred Patients with Facial DyskinesiasOphthalmology, 1987
- Botulinum A toxin for cranial‐cervical dystoniaNeurology, 1987
- Botulinum Injection Therapy for BlepharospasmClinical Neuropharmacology, 1986
- The Use of Botulinum Toxin in the Medical Management of Benign Essential BlepharospasmOphthalmology, 1986
- Blepharospasm, Meige syndronfie, and hemifacial SpasmNeurology, 1985
- Hemifacial Spasm Treated With Botulinum A Toxin InjectionArchives of Ophthalmology (1950), 1985
- Botulinum A Toxin Injection as a Treatment for BlepharospasmArchives of Ophthalmology (1950), 1985
- Treatment of Blepharospasm With Botulinum ToxinArchives of Ophthalmology (1950), 1984
- Antitoxin Levels in Botulism Patients Treated with Trivalent Equine Botulism Antitoxin to Toxin Types A, B, and EThe Journal of Infectious Diseases, 1984